10.1371/journal.pone.0161313.g005 Kyle E. Korolowicz Kyle E. Korolowicz Radhakrishnan P. Iyer Radhakrishnan P. Iyer Stefanie Czerwinski Stefanie Czerwinski Manasa Suresh Manasa Suresh Junming Yang Junming Yang Seetharamaiyer Padmanabhan Seetharamaiyer Padmanabhan Anjaneyulu Sheri Anjaneyulu Sheri Rajendra K. Pandey Rajendra K. Pandey Jeffrey Skell Jeffrey Skell Judith K. Marquis Judith K. Marquis Bhaskar V. Kallakury Bhaskar V. Kallakury Robin D. Tucker Robin D. Tucker Stephan Menne Stephan Menne SB 9200 treatment is associated with dose-dependent, transient increases of SDH but not of other liver enzymes. Public Library of Science 2016 SB 9200 treatment HBV SB 9200 Treatment Host Innate Immunity Associated serum WHV surface antigen hepatitis B virus SB 9200 1.6 log 10 declines IFN sensor proteins NOD RNA woodchuck hepatitis virus 3.7 log 10 reductions serum WHV DNA 2016-08-23 17:30:01 Figure https://plos.figshare.com/articles/figure/SB_9200_treatment_is_associated_with_dose-dependent_transient_increases_of_SDH_but_not_of_other_liver_enzymes_/3754305 <p>Changes in mean serum levels of SDH, AST and ALT in response to SB 9200 treatment at a low (<b>A</b>) or high dose (<b>B</b>). Changes in mean serum WHV DNA relative to T<sub>0</sub> is plotted on the left y-axis. Error bars represent the standard error of the mean.</p>